Gastrointestinal infections, especially diarrheal diseases, are responsible for substantial morbidity and mortality worldwide. A wide array of bacterial, protozoal, and viral pathogens is responsible for gastrointestinal tract infections. Young children, the elderly, and immunocompromised patients are at greatest risk for more severe disease and complications. Poor sanitation, inadequate water supplies, and increasing globalization of food transport systems all predispose to the development of large epidemics of food- and waterborne outbreaks of gastrointestinal disease. Success of treatment, when clinically indicated, is increasingly threatened by rising rates of antimicrobial resistance among gastrointestinal pathogens.
Sansure has been deeply involved in the gastrointestinal infection field for many years, and has developed a series of products, making it a provider of a full scenario-based integrated solution.Sansure Biotech will give full play to its technical and product advantages and launch more products to provide a more complete and holistic solution to help realize the dream of health for all in the future.